CARA - Cara Therapeutics Inks Distribution Deal Stock Will Push Higher
I am continuing to add companies into my own private portfolio. This portfolio is geared towards cannabis pharmaceuticals. I believe there is significant upside in this sector. Cara Therapeutics (CARA) has hit my radar as a company with tremendous opportunities. Currently, the company has begun the critical Phase 3 trials of their key drug that has the potential to become a blockbuster drug (Sales exceeding $1 billion), and the FDA has given the drug a Breakthrough Therapy designation.
Previously, Cara had used the drug to test on two different pain conditions. There were